These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene. Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637 [TBL] [Abstract][Full Text] [Related]
25. Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers. Go EP; Ding H; Zhang S; Ringe RP; Nicely N; Hua D; Steinbock RT; Golabek M; Alin J; Alam SM; Cupo A; Haynes BF; Kappes JC; Moore JP; Sodroski JG; Desaire H J Virol; 2017 May; 91(9):. PubMed ID: 28202756 [TBL] [Abstract][Full Text] [Related]
26. Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds. Madani N; Princiotto AM; Easterhoff D; Bradley T; Luo K; Williams WB; Liao HX; Moody MA; Phad GE; Vázquez Bernat N; Melillo B; Santra S; Smith AB; Karlsson Hedestam GB; Haynes B; Sodroski J J Virol; 2016 May; 90(10):5031-5046. PubMed ID: 26962221 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination. Torrents de la Peña A; de Taeye SW; Sliepen K; LaBranche CC; Burger JA; Schermer EE; Montefiori DC; Moore JP; Klasse PJ; Sanders RW J Virol; 2018 Apr; 92(8):. PubMed ID: 29367243 [TBL] [Abstract][Full Text] [Related]
28. Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates. Verkerke HP; Williams JA; Guttman M; Simonich CA; Liang Y; Filipavicius M; Hu SL; Overbaugh J; Lee KK J Virol; 2016 Oct; 90(20):9471-82. PubMed ID: 27512064 [TBL] [Abstract][Full Text] [Related]
29. Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties. Guenaga J; de Val N; Tran K; Feng Y; Satchwell K; Ward AB; Wyatt RT PLoS Pathog; 2015 Jan; 11(1):e1004570. PubMed ID: 25569572 [TBL] [Abstract][Full Text] [Related]
30. Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses. Beltran-Pavez C; Bontjer I; Gonzalez N; Pernas M; Merino-Mansilla A; Olvera A; Miro JM; Brander C; Alcami J; Sanders RW; Sanchez-Merino V; Yuste E J Virol; 2022 Jan; 96(1):e0134321. PubMed ID: 34668778 [TBL] [Abstract][Full Text] [Related]
31. Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses. Perdiguero B; Gómez CE; García-Arriaza J; Sánchez-Corzo C; Sorzano CÓS; Wilmschen S; von Laer D; Asbach B; Schmalzl C; Peterhoff D; Ding S; Wagner R; Kimpel J; Levy Y; Pantaleo G; Esteban M Front Immunol; 2019; 10():2941. PubMed ID: 31921191 [TBL] [Abstract][Full Text] [Related]
32. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site. Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402 [TBL] [Abstract][Full Text] [Related]
33. The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization. Schorcht A; Cottrell CA; Pugach P; Ringe RP; Han AX; Allen JD; van den Kerkhof TLGM; Seabright GE; Schermer EE; Ketas TJ; Burger JA; van Schooten J; LaBranche CC; Ozorowski G; de Val N; Bader DLV; Schuitemaker H; Russell CA; Montefiori DC; van Gils MJ; Crispin M; Klasse PJ; Ward AB; Moore JP; Sanders RW J Virol; 2022 Jan; 96(1):e0155221. PubMed ID: 34669426 [TBL] [Abstract][Full Text] [Related]
34. Structural Features of Broadly Neutralizing Antibodies and Rational Design of Vaccine. Zhou T; Xu K Adv Exp Med Biol; 2018; 1075():73-95. PubMed ID: 30030790 [TBL] [Abstract][Full Text] [Related]
35. Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies. LaBranche CC; Henderson R; Hsu A; Behrens S; Chen X; Zhou T; Wiehe K; Saunders KO; Alam SM; Bonsignori M; Borgnia MJ; Sattentau QJ; Eaton A; Greene K; Gao H; Liao HX; Williams WB; Peacock J; Tang H; Perez LG; Edwards RJ; Kepler TB; Korber BT; Kwong PD; Mascola JR; Acharya P; Haynes BF; Montefiori DC PLoS Pathog; 2019 Sep; 15(9):e1008026. PubMed ID: 31527908 [TBL] [Abstract][Full Text] [Related]
36. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop. Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999 [TBL] [Abstract][Full Text] [Related]
37. [Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination]. Vzorov AN; Uryvaev LV Mol Biol (Mosk); 2017; 51(6):945-957. PubMed ID: 29271959 [TBL] [Abstract][Full Text] [Related]
38. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody. Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262 [TBL] [Abstract][Full Text] [Related]